Jane Street
DMRA

Jane Street’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Jane Street’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$296K Buy
+11,420
New +$294K ﹤0.01% 9267
2024
Q2 		– Sell
-1,049
Closed -$20.4K – 9675
2024
Q1 		$20.4K Buy
+1,049
New +$18.6K ﹤0.01% 8897

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Jane Street's DMRA Position: Q1 2026 in Review

Jane Street opened a new position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q1 2026: 11,420 shares worth $296K. The stake represents ﹤0.01% of the portfolio and ranks #9267 among its holdings. This is a return to the name: Jane Street previously reported a position in DMRA as recently as Q1 2024.

Jane Street first reported a position in DMRA in Q1 2024 and has held it in 2 quarters since. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

  • Jane Street held 11,420 shares of Damora Therapeutics, Inc. Ordinary Shares worth $296K as of Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares was a new Jane Street position in Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9267 holding.
  • Jane Street first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q1 2024 and has held it in 2 quarters since.
  • 65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.